GET /trials/source/12/?page=38
HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 380,
    "next": null,
    "previous": "http://api.gregory-ms.com/trials/source/12/?page=37",
    "results": [
        {
            "title": "Ocrelizumab Access by Socio-Economic Status",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Drug: Ocrelizumab<br/><b>Sponsors</b>:    Brigham and Women's Hospital;   Genentech, Inc.;   Boston Medical Center<br/><b>Not yet recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05131984?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2021-11-23T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2021-11-23T15:17:43Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Improving Prospective Memory Via Telehealth",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Interventions</b>:    Behavioral: Prospective Memory Intervention;   Behavioral: Educational<br/><b>Sponsor</b>:    Saint Francis Care<br/><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05129293?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2021-11-22T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2021-11-22T13:57:43Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "An Individualized-health eLibrary App for People With Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Device: SavvyHealth<br/><b>Sponsor</b>:    University of Illinois at Urbana-Champaign<br/><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05124600?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2021-11-18T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2021-11-18T18:07:42Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "A Health Action Process Approach Online Intervention for People With Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Behavioral: MSPA eClass<br/><b>Sponsor</b>:    University of Illinois at Urbana-Champaign<br/><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05124522?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2021-11-18T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2021-11-18T18:07:42Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Longitudinal Assessment of Iron Rims in MS Lesions",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Interventions</b>:    Biological: Blood sample provided;   Diagnostic Test: 7-T MRI scan<br/><b>Sponsors</b>:    Nottingham University Hospitals NHS Trust;   Johns Hopkins University<br/><b>Not yet recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05123443?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2021-11-17T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2021-11-17T13:37:42Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Cognition and HRQoL in Adults With Highly-active RMS in Year 3 and 4 After Initial Mavenclad® Dose (CLARIFY MS Extension)",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Drug: Mavenclad®<br/><b>Sponsor</b>:    Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany<br/><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04776213?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2021-03-01T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2021-03-08T12:17:02Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations (SARS)",
            "summary": "<b>Conditions</b>:    SARS-CoV Infection;   COVID-19;   Allergic Reaction;   Mast Cell Disorder;   Non-atopic<br/><b>Interventions</b>:    Biological: Moderna COVID-19 Vaccine;   Biological: Pfizer-BioNTech COVID-19 Vaccine;   Biological: Placebo<br/><b>Sponsors</b>:    National Institute of Allergy and Infectious Diseases (NIAID);   Immune Tolerance Network (ITN);   Rho Federal Systems Division, Inc.<br/><b>Not yet recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04761822?term=biontech&sfpd_d=14&sel_rss=new14",
            "published_date": "2021-02-21T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2021-03-02T14:12:09Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Antibody Response to COVID-19 Vaccines in Liver Disease Patients",
            "summary": "<b>Condition</b>:    Chronic Liver Disease<br/><b>Interventions</b>:    Biological: BNT162b2;   Biological: CoronaVac;   Biological: AZD1222<br/><b>Sponsor</b>:    Humanity & Health Medical Group Limited<br/><b>Not yet recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04775069?term=biontech&sfpd_d=14&sel_rss=new14",
            "published_date": "2021-03-01T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2021-01-03T01:00:00Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older",
            "summary": "<b>Conditions</b>:    SARS-CoV-2 Infection;   COVID-19;   Maternal Immunization<br/><b>Interventions</b>:    Biological: BNT162b2;   Other: Placebo<br/><b>Sponsors</b>:    BioNTech SE;   Pfizer<br/><b>Not yet recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04754594?term=biontech&sfpd_d=14&sel_rss=new14",
            "published_date": "2021-02-15T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2021-02-27T01:00:00Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE)",
            "summary": "<b>Condition</b>:    SARS-CoV Infection<br/><b>Interventions</b>:    Biological: COMIRNATY - BioNTech Manufacturing GmbH;   Biological: COVID-19 Vaccine Moderna dispersion for injection - MODERNA BIOTECH;   Biological: COVID-19 Vaccine AstraZeneca suspension for injection<br/><b>Sponsors</b>:    Jens D Lundgren, MD;   Ministry of the Interior and Health, Denmark<br/><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04760132?term=biontech&sfpd_d=14&sel_rss=new14",
            "published_date": "2021-02-18T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2021-02-27T01:00:00Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        }
    ]
}